Observers of Siemens Medical Systems may need a scorecard to keeptrack of recent personnel changes in the German vendor's MRI division.The moves include the first American promoted to head worldwideMRI operations. Thomas J. Miller was sent to Siemens
Observers of Siemens Medical Systems may need a scorecard to keeptrack of recent personnel changes in the German vendor's MRI division.The moves include the first American promoted to head worldwideMRI operations.
Thomas J. Miller was sent to Siemens headquarters in Erlangen,Germany, in early May to oversee long-range development of MRIproducts, according to Anne Deery, MRI communications managerfor Siemens.
Miller had previously been division manager of MRI in the U.S.A strong performance in that position resulted in his advancementto worldwide MRI chief, Deery said.
"This is a huge promotion for Tom, and (indicative of)the work he's done," she told SCAN. "We had a very goodyear last year."
Miller's promotion has set off a chain reaction of personnelchanges that has Siemens staffers crisscrossing the Atlantic:
These moves will benefit Siemens by strengthening the bondsbetween the company's European and American divisions, Deery said.That should lead to a more competitive company as Siemens becomesmore responsive to the needs of equipment users in the U.S.
"We've done everything we can to improve communicationsand sometimes that involves a change of personnel," Deerysaid. "We feel the American view on what a product shouldbe like is very important, and Tom (Miller) has been here sincethe start of MRI at Siemens."
BRIEFLY NOTED:
Edward H. Richards, vice president of sales and marketing atASHS, was formerly with mobile imaging competitor Maxum Healthof Dallas, where he served as sales manager. Richard W. Townley,vice president and general manager of contract services, was vicepresident with BOC/Airco, an international industrial gas andhealth-care company.
ASHS has trimmed unprofitable service businesses and pulleditself out from under a large debt load. The firm had a slightprofit of $34,000 in its first quarter of 1992 (end-March), comparedto a loss (before extraordinary item) of $66,000 in the same periodof 1991. The extraordinary item last year was a gain of $2 millionfrom the repurchase of senior subordinated debt at a discount.Revenue, however, dipped for the first quarter, from $15.7 millionin 1991 to $14 million this year.
BRIEFLY NOTED:
Corday was previously president and CEO of Goldcor of Chicago,a consulting firm specializing in health-care acquisitions. Shereplaces senior vice president Joseph M. O'Hehir, who left thefirm this year to start up his own medical imaging consultingbusiness (SCAN 5/6/92).
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.